Healthcare -
Biotechnology - NASDAQ - US
$ 4.41
-2.65 %
$ 204 M
Market Cap
-1.55
P/E
FDMT - REVENUE
Revenue FDMT - 4D Molecular Therapeutics, Inc.
20.7 M
LAST VALUE
7.18%
2 YEAR CAGR
7.96%
5 YEAR CAGR
0.00%
10 YEAR CAGR